In Vivo Gene Therapy for Canine SCID-X1 Using Cocal-Pseudotyped Lentiviral Vector

遗传增强 病毒载体 离体 祖细胞 水泡性口炎病毒 基因传递 体内 严重联合免疫缺陷 病毒学 癌症研究 生物 免疫学 基因签名 干细胞 医学 病毒 基因 基因表达 细胞生物学 遗传学 重组DNA
作者
Yogendra Singh Rajawat,Olivier Humbert,Savannah Cook,Stefan Radtke,Dnyanada Pande,Mark Enstrom,Martin E. Wohlfahrt,Hans‐Peter Kiem
出处
期刊:Human Gene Therapy [Mary Ann Liebert]
卷期号:32 (1-2): 113-127 被引量:9
标识
DOI:10.1089/hum.2020.127
摘要

Hematopoietic stem and progenitor cell (HSPC)-based ex vivo gene therapy has demonstrated clinical success for X-linked severe combined immunodeficiency (SCID-X1) patients who lack a suitable donor for HSPC transplantation. Nevertheless, this form of treatment is associated with an increased risk of infectious disease complications and genotoxicity mainly due to the conditioning regimen. In addition, ex vivo gene therapy approaches require sophisticated facilities to manufacture gene-modified cells and to care for the patients after chemotherapy. Considering these impediments, we have developed an in vivo gene therapy approach to treat canine SCID-X1 after HSPC mobilization and systemic delivery of the therapeutic vector. Here, we investigated the use of the cocal envelope to pseudotype a lentiviral (LV) vector expressing a functional gammaC gene. The cocal envelope is resistant to serum inactivation compared with the commonly used vesicular stomatitis virus envelope glycoprotein (VSV-G) envelope and thus well suited for systemic delivery. Two SCID-X1 neonatal canines treated with this approach achieved long-term therapeutic immune reconstitution with no prior conditioning. Therapeutic levels of gene-corrected CD3+ T cells were demonstrated for at least 16 months, and all other correlates of T cell functionality were within normal range. Retroviral integration-site analysis demonstrated polyclonal T cell reconstitution. Comparative analysis of integration profiles of foamy viral (FV) vector and cocal LV vector after in vivo gene therapy found distinct integration-site patterns. These data demonstrate that clinically relevant and durable correction of canine SCID-X1 can be achieved with in vivo delivery of cocal LV. Since manufacturing of cocal LV is similar to VSV-G LV, this approach is easily translatable to a clinical setting, thus providing for a highly portable and accessible gene therapy platform for SCID-X1.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mmyhn发布了新的文献求助10
刚刚
Leonardi给王雨薇的求助进行了留言
刚刚
cloud发布了新的文献求助10
1秒前
英俊的铭应助ww采纳,获得10
2秒前
esyncoms发布了新的文献求助10
2秒前
田様应助fanny采纳,获得10
2秒前
3秒前
GGBOND2024应助小张采纳,获得10
3秒前
4秒前
NexusExplorer应助朱荧荧采纳,获得10
5秒前
7秒前
Jasper应助jjkjkjkjj采纳,获得10
8秒前
8秒前
云中应助天真的半莲采纳,获得10
8秒前
9秒前
Qinqinasm完成签到,获得积分10
9秒前
9秒前
调研昵称发布了新的文献求助10
10秒前
搜集达人应助顺心绮兰采纳,获得10
11秒前
清萍红檀发布了新的文献求助10
12秒前
ww发布了新的文献求助10
13秒前
14秒前
14秒前
15秒前
华仔应助young采纳,获得10
15秒前
16秒前
云汐儿应助认真科研采纳,获得10
16秒前
Johann完成签到,获得积分10
16秒前
脑洞疼应助wm采纳,获得10
17秒前
科研通AI2S应助QQQQQQQ采纳,获得10
17秒前
18秒前
19秒前
小葡萄icon完成签到 ,获得积分10
20秒前
Leeny发布了新的文献求助10
21秒前
希望天下0贩的0应助Swan采纳,获得10
21秒前
21秒前
fanny完成签到,获得积分10
22秒前
苗修杰完成签到,获得积分10
22秒前
sb三百问给sb三百问的求助进行了留言
23秒前
23秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
Very-high-order BVD Schemes Using β-variable THINC Method 568
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3136013
求助须知:如何正确求助?哪些是违规求助? 2786835
关于积分的说明 7779716
捐赠科研通 2443045
什么是DOI,文献DOI怎么找? 1298822
科研通“疑难数据库(出版商)”最低求助积分说明 625232
版权声明 600870